Baseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative Chemotherapy

Nutrition and Cancer

Volumn 46, Issue 2, 2003, Pages 148-157

  Slaviero, Kellie A ^a   Read, Jane A ^b   Clarke, Stephen J ^b   Rivory, Laurent P ^a,b  

^a University of Sydney   (Australia)

^b SYDNEY CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER PATIENT; HUMAN; MALNUTRITION; MEDICAL ASSESSMENT; NUTRITIONAL STATUS; PALLIATIVE THERAPY; SCORING SYSTEM; WEIGHT REDUCTION;

EID: 0344628796     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC4602_07     Document Type: Article

References (58)

1. Albrecht JT and Canada TW: Cachexia and anorexia in malignancy. Hematol Oncol Clin N Am 10, 791-800, 1996.
2. Ottery FD: Cancer cachexia: prevention, early diagnosis, and management. Cancer Pract 2, 123-131, 1994.
3. Tisdale MJ: Biology of cachexia. J Ntl Cancer Instit 89, 1763-1773, 1997.
4. Yeh SS and Schuster MW: Geriatric cachexia: the role of cytokines. American J Clin Nutr 70, 183-197, 1999.
5. McMahon K, Decker G, and Ottery FD: Integrating proactive nutritional assessment in clinical practices to prevent complications and cost. Semin Oncol 25, 20-27, 1998.
6. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491-497, 1980.
7. Andreyev HJ, Norman AR, Oates J, and Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503-509, 1998.
8. Buccheri G and Ferrigno D: Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer 34, 433-440, 2001.
9. Vigano A, Bruera E, Jhangri GS, Newman SC, Fields AL, et al.: Clinical survival predictors in patients with advanced cancer. Arch Int Med 160, 861-868, 2000.
10. Saxe GA, Rock CL, Wicha MS, and Schottenfeld D: Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 53, 241-253, 1999.
11. Finan MA, Hoffman MS, Chambers R, Florica JV, DeCesare S, et al.: Body mass predicts the survival of patients with new International Federation of Gynecology and Obstetrics Stage IB1 and IB2 cervical carcinoma treated with radical hysterectomy. Cancer 83, 98-102, 1998.
12. Braga M, Gianotti L, Nespoli L, Radaelli G, and Di Carlo V: Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 137, 174-180, 2002.
13. Ottery FD: Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 22, 98-111, 1995.
14. Omran ML and Morley JE: Assessment of protein energy malnutrition in older persons. Part I: History, examination, body composition, and screening tools. Nutrition 16, 50-63, 2000.
15. Louay Omran M and Morley JE: Assessment of protein energy malnutrition in older persons. Part II: Laboratory evaluation. Nutrition 16, 131-140, 2000.
16. Shils ME and Shike M: Nutritional support of the cancer patient. In Modern Nutrition in Health and Disease, Shils JAO, Shike M, and Ross AC (eds). Baltimore, MD: Williams & Wilkins, 1999, pp 1297-1325.
17. Bauer J, Capra S, and Ferguson M: Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56, 779-785, 2002.
18. Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, and Falkmer UG: Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 16, 33-42, 2002.
19. Duguet A, Bachmann P, Lallemand Y, and Blanc-Vincent MP: (Good clinical practice in nutritional management in cancer patients: malnutrition and nutritional assessment). Bull Cancer 86, 997-1016, 1999.
20. Delmore G: Assessment of nutritional status in cancer patients: widely neglected? Support Care Cancer 5, 376-380, 1997.
21. Guigoz Y, Vellas B, and Garry PJ: Mini Nutritional Assessment: a practical assessment for the grading the nutritional state of elderly patients. In Facts and Resarch in Gerontology. New York, Springer, 1994, pp 15-59.
22. Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE, et al.: Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN 8, 153-159, 1984.
23. Ingenbleek Y and Carpentier YA: A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res 55, 91-101, 1985.
24. Lukaski HC, Bolonchuk WW, Hall CB, and Siders WA: Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60, 1327-1332, 1986.
25. Garrow JS and Webster J: Quetelet's index (W/H) as a measure of fatness. Int J Obes 9, 147-153, 1985.
26. Beck AM, Ovesen L, and Osler M: The "Mini Nutritional Assessment" (MNA) and the "Determine Your Nutritional Health" Checklist (NSI Checklist) as predictors of morbidity and mortality in an elderly Danish population. Br J Nutr 81, 31-36, 1999.
27. Vellas B, Guigoz Y, Baumgartner M, Garry PJ, Lauque S, et al.: Relationships between nutritional markers and the mini-nutritional assessment in 155 older persons. J Am Geriatr Soc 48, 1300-1309, 2000.
28. Christensson L, Unosson M, and Ek AC: Evaluation of nutritional assessment techniques in elderly people newly admitted to municipal care. Eur J Clin Nutr 56, 810-818, 2002.
29. Donini LM, de Felice MR, Tassi L, de Bernardini L, Pinto A, et al.: A "proportional and objective score" for the mini nutritional assessment in long-term geriatric care. J Nutr Health Aging 6, 141-146, 2002.
30. Zulian GB, Gold G, Herrmann F, and Michel JP: Mini Nutritional Assessment and cancer. Nestle Nutr Workshop Ser Clin Perform Programme 1, 93-98, 1999.
31. Guigoz Y, Vellas B, and Garry PJ: Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 54, S59-S65, 1996.
32. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, et al.: What is subjective global assessment of nutritional status? JPEN 11, 8-13, 1987.
33. Ottery FD: Rethinking nutritional support of the cancer patient: the new field of nutritional oncology. Semin Oncol 21, 770-778, 1994.
34. Ek AC, Unosson M, Larsson J, Ganowiak W, and Bjurulf P: Interrater variability and validity in subjective nutritional assessment of elderly patients. Scand J Caring Sci 10, 163-168, 1996.
35. Duerksen DR, Yeo TA, Siemens JL, and O'Connor MP: The validity and reproducibility of clinical assessment of nutritional status in the elderly. Nutrition 16, 740-744, 2000.
36. Mahmoud FA and Rivera NI: The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 4, 250-255, 2002.
37. O'Gorman P, McMillan DC, and McArdle CS: Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer 35, 127-129, 1999.
38. Barber MD, Ross JA, and Fearon KC: Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35, 106-110, 1999.
39. Staal-van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, and Wouters EF: Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13, 2600-2605, 1995.
40. Cahlin C, Korner A, Axelsson H, Wang W, Lundholm K, and Svanberg E: Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 B1 background and eicosanoid-dependent cachexia. Cancer Res 60, 5488-5493, 2000.
41. Falconer JS, Fearon KC, Plester CE, Ross JA, and Carter DC: Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219, 325-331, 1994.
42. Shrivastava A and Aggarwal BB: Cytokines as biological regulators of homeostasis. J Biol Regul Homeost Agents 12, 1-24, 1998.
43. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357, 539-545, 2001.
44. Ardestani SK, Inserra P, Solkoff D, and Watson RR: The role of cytokines and chemokines on tumor progression: a review. Cancer Detect Prev 23, 215-225, 1999.
45. Rivory LP, Slaviero K, and Clarke SJ: Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients with an acute-phase response. Br J Cancer 87, 277-280, 2002.
46. Mantovani G, Maccio A, Madeddu C, Mura L, Gramignano G, et al.: Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 98, 84-91, 2002.
47. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, et al.: Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 52, 3317-3322, 1992.
48. Kato K, Hitsuda Y, Kawasaki Y, Igishi T, Yasuda K, et al.: (The value of serum C-reactive protein as a survival determinant in patients with advanced non-small-cell lung cancer.) Nihon Kokyuki Gakkai Zasshi 38, 575-580, 2000.
49. Falconer JS, Fearon KC, Ross JA, Elton R, Wigmore SJ, et al.: Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75, 2077-2082, 1995.
50. Legouffe E, Rodriguez C, Picot MC, Richard B, Klein B, et al.: C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma 31, 351-357, 1998.
51. Nozoe T, Matsumata T, Kitamura M, and Sugimachi K: Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 176, 335-338, 1998.
52. Nozoe T, Matsumata T, and Sugimachi K: Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23, 263-266, 2000.
53. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, et al.: Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39, 210-213, 2001.
54. Fearon KC, Falconer JS, Slater C, McMillan DC, Ross JA, et al.: Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response (see comments). Ann Surg 227, 249-254, 1998.
55. O'Gorman P, McMillan DC, and McArdle CS: Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer 32, 76-80, 1998.
56. McMillan DC, Scott HR, Watson WS, Preston T, Milroy R, et al.: Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31, 101-105, 1998.
57. Fritz T, Hollwarth I, Romaschow M, and Schlag P: The predictive role of bioelectrical impedance analysis (BIA) in postoperative complications of cancer patients. Eur J Surg Oncol 16, 326-331, 1990.
58. Simons JP, Schols AM, Westerterp KR, Ten Velde GP, and Wouters EF: Bioelectrical impedance analysis to assess changes in total body water in patients with cancer. Clin Nutr 18, 35-39, 1999.